# WM Technology, Inc.: financial statements, quarterly

MAPS · OTC · CIK 1779474 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/maps.md) · [Financials](/companies/maps/financials.md) · [Filings](/companies/maps/filings.md) · [Insiders](/companies/maps/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/maps/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [46.7](/filings/0001779474-24-000062.md) | [46.5 d](/filings/0001779474-25-000007.md) | [44.4](/filings/0001779474-25-000018.md) | [45.9](/filings/0001779474-25-000035.md) | [46.6](/filings/0001779474-25-000045.md) | [47.7 d](/filings/0001779474-26-000013.md) | [44.6](/filings/0001779474-26-000023.md) | [44.8](/filings/0001779474-26-000033.md) | [42.2](/filings/0001779474-25-000045.md) | [43.1 d](/filings/0001779474-26-000013.md) | [43.6](/filings/0001779474-26-000023.md) | [42.4](/filings/0001779474-26-000033.md) |
| Cost of revenue | $m | [3.0](/filings/0001779474-24-000062.md) | [2.8 d](/filings/0001779474-25-000007.md) | [2.3](/filings/0001779474-25-000018.md) | [2.2](/filings/0001779474-25-000035.md) | [2.2](/filings/0001779474-25-000045.md) | [2.3 d](/filings/0001779474-26-000013.md) | [2.2](/filings/0001779474-26-000023.md) | [2.3](/filings/0001779474-26-000033.md) | [2.1](/filings/0001779474-25-000045.md) | [2.2 d](/filings/0001779474-26-000013.md) | [2.2](/filings/0001779474-26-000023.md) | [2.5](/filings/0001779474-26-000033.md) |
| Research and development | $m | [7.7](/filings/0001779474-24-000062.md) | [8.1 d](/filings/0001779474-25-000007.md) | [9.2](/filings/0001779474-25-000018.md) | [9.6](/filings/0001779474-25-000035.md) | [9.5](/filings/0001779474-25-000045.md) | [8.1 d](/filings/0001779474-26-000013.md) | [9.7](/filings/0001779474-26-000023.md) | [8.9](/filings/0001779474-26-000033.md) | [6.4](/filings/0001779474-25-000045.md) | [6.2 d](/filings/0001779474-26-000013.md) | [8.7](/filings/0001779474-26-000023.md) | [8.7](/filings/0001779474-26-000033.md) |
| Operating income | $m | [(5.5)](/filings/0001779474-24-000062.md) | [(12.5) d](/filings/0001779474-25-000007.md) | [3.8](/filings/0001779474-25-000018.md) | [1.2](/filings/0001779474-25-000035.md) | [5.2](/filings/0001779474-25-000045.md) | [4.6 d](/filings/0001779474-26-000013.md) | [2.6](/filings/0001779474-26-000023.md) | [1.9](/filings/0001779474-26-000033.md) | [2.0](/filings/0001779474-25-000045.md) | [(5.8) d](/filings/0001779474-26-000013.md) | [0.2](/filings/0001779474-26-000023.md) | [2.4](/filings/0001779474-26-000033.md) |
| Income tax | $m | [0.0](/filings/0001779474-24-000062.md) | [0.1 d](/filings/0001779474-25-000007.md) | [0.0](/filings/0001779474-25-000018.md) | [0.0](/filings/0001779474-25-000035.md) | [0.0](/filings/0001779474-25-000045.md) | [(0.0) d](/filings/0001779474-26-000013.md) | [0.0](/filings/0001779474-26-000023.md) | [0.0](/filings/0001779474-26-000033.md) | [0.0](/filings/0001779474-25-000045.md) | [0.1 d](/filings/0001779474-26-000013.md) | [0.0](/filings/0001779474-26-000023.md) | [0.0](/filings/0001779474-26-000033.md) |
| Net income | $m | [(1.5)](/filings/0001779474-24-000062.md) | [(7.1) d](/filings/0001779474-25-000007.md) | [1.2](/filings/0001779474-25-000018.md) | [0.7](/filings/0001779474-25-000035.md) | [3.3](/filings/0001779474-25-000045.md) | [2.4 d](/filings/0001779474-26-000013.md) | [1.6](/filings/0001779474-26-000023.md) | [1.4](/filings/0001779474-26-000033.md) | [2.5](/filings/0001779474-25-000045.md) | [(3.6) d](/filings/0001779474-26-000013.md) | [1.2](/filings/0001779474-26-000023.md) | [2.0](/filings/0001779474-26-000033.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.01](/filings/0001779474-25-000018.md) | not reported | not reported | not reported | [0.02](/filings/0001779474-26-000023.md) | [0.01](/filings/0001779474-26-000033.md) | not reported | not reported | [0.01](/filings/0001779474-26-000023.md) | [0.02](/filings/0001779474-26-000033.md) |
| Basic EPS | $ per share | not reported | not reported | [0.01](/filings/0001779474-25-000018.md) | not reported | not reported | not reported | [0.02](/filings/0001779474-26-000023.md) | [0.01](/filings/0001779474-26-000033.md) | not reported | not reported | [0.01](/filings/0001779474-26-000023.md) | [0.02](/filings/0001779474-26-000033.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [27.7](/filings/0001779474-23-000076.md) | [34.4](/filings/0001779474-25-000007.md) | [35.7](/filings/0001779474-24-000025.md) | [41.3](/filings/0001779474-24-000043.md) | [45.0](/filings/0001779474-24-000062.md) | [52.0](/filings/0001779474-26-000013.md) | [53.3](/filings/0001779474-25-000018.md) | [59.0](/filings/0001779474-25-000035.md) | [62.6](/filings/0001779474-25-000045.md) | [62.4](/filings/0001779474-26-000033.md) | [45.5](/filings/0001779474-26-000023.md) | [60.5](/filings/0001779474-26-000033.md) |
| Current assets | $m | [46.9](/filings/0001779474-23-000076.md) | [51.5](/filings/0001779474-25-000007.md) | [50.3](/filings/0001779474-24-000025.md) | [53.8](/filings/0001779474-24-000043.md) | [59.4](/filings/0001779474-24-000062.md) | [69.5](/filings/0001779474-26-000013.md) | [72.0](/filings/0001779474-25-000018.md) | [77.4](/filings/0001779474-25-000035.md) | [81.6](/filings/0001779474-25-000045.md) | [84.9](/filings/0001779474-26-000033.md) | [80.5](/filings/0001779474-26-000023.md) | [85.2](/filings/0001779474-26-000033.md) |
| Total assets | $m | [179](/filings/0001779474-23-000076.md) | [167](/filings/0001779474-25-000007.md) | [166](/filings/0001779474-24-000025.md) | [168](/filings/0001779474-24-000043.md) | [174](/filings/0001779474-24-000062.md) | [182](/filings/0001779474-26-000013.md) | [184](/filings/0001779474-25-000018.md) | [188](/filings/0001779474-25-000035.md) | [193](/filings/0001779474-25-000045.md) | [191](/filings/0001779474-26-000033.md) | [186](/filings/0001779474-26-000023.md) | [191](/filings/0001779474-26-000033.md) |
| Current liabilities | $m | [31.1](/filings/0001779474-23-000076.md) | [33.7](/filings/0001779474-25-000007.md) | [30.0](/filings/0001779474-24-000025.md) | [30.3](/filings/0001779474-24-000043.md) | [27.8](/filings/0001779474-24-000062.md) | [30.4](/filings/0001779474-26-000013.md) | [32.2](/filings/0001779474-25-000018.md) | [32.2](/filings/0001779474-25-000035.md) | [32.1](/filings/0001779474-25-000045.md) | [36.2](/filings/0001779474-26-000033.md) | [30.0](/filings/0001779474-26-000023.md) | [31.3](/filings/0001779474-26-000033.md) |
| Total liabilities | $m | [63.9](/filings/0001779474-23-000076.md) | [63.9](/filings/0001779474-25-000007.md) | [59.0](/filings/0001779474-24-000025.md) | [58.8](/filings/0001779474-24-000043.md) | [58.6](/filings/0001779474-24-000062.md) | [61.8](/filings/0001779474-26-000013.md) | [60.1](/filings/0001779474-25-000018.md) | [60.1](/filings/0001779474-25-000035.md) | [57.6](/filings/0001779474-25-000045.md) | [58.9](/filings/0001779474-26-000033.md) | [51.6](/filings/0001779474-26-000023.md) | [51.7](/filings/0001779474-26-000033.md) |
| Shareholders' equity | $m | [19.9](/filings/0001779474-23-000076.md) | [16.4](/filings/0001779474-25-000007.md) | [20.8](/filings/0001779474-24-000025.md) | [24.5](/filings/0001779474-24-000043.md) | [29.5](/filings/0001779474-24-000062.md) | [36.1](/filings/0001779474-26-000013.md) | [48.5](/filings/0001779474-25-000018.md) | [52.7](/filings/0001779474-25-000035.md) | [56.9](/filings/0001779474-25-000045.md) | [57.2](/filings/0001779474-26-000033.md) | [59.7](/filings/0001779474-26-000023.md) | [62.8](/filings/0001779474-26-000033.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.3 d](/filings/0001779474-24-000062.md) | [10.5 d](/filings/0001779474-25-000007.md) | [7.4](/filings/0001779474-25-000018.md) | [12.7 d](/filings/0001779474-25-000035.md) | [7.2 d](/filings/0001779474-25-000045.md) | [9.4 d](/filings/0001779474-26-000013.md) | [5.7](/filings/0001779474-26-000023.md) | [11.1 d](/filings/0001779474-26-000033.md) | [6.4 d](/filings/0001779474-25-000045.md) | [3.0 d](/filings/0001779474-26-000013.md) | [(1.3)](/filings/0001779474-26-000023.md) | [8.2 d](/filings/0001779474-26-000033.md) |
| Capital expenditure | $m | [3.1 d](/filings/0001779474-23-000076.md) | [3.0 d](/filings/0001779474-25-000007.md) | [4.5](/filings/0001779474-25-000018.md) | [2.6 d](/filings/0001779474-25-000035.md) | [2.4 d](/filings/0001779474-25-000045.md) | [2.1 d](/filings/0001779474-26-000013.md) | [3.7](/filings/0001779474-26-000023.md) | [2.8 d](/filings/0001779474-26-000033.md) | [2.9 d](/filings/0001779474-25-000045.md) | [3.3 d](/filings/0001779474-26-000013.md) | [2.5](/filings/0001779474-26-000023.md) | [4.7 d](/filings/0001779474-26-000033.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [96.0](/filings/0001779474-25-000018.md) | [107](/filings/0001779474-26-000023.md) | [108](/filings/0001779474-26-000033.md) | [111](/filings/0001779474-26-000023.md) | [112](/filings/0001779474-26-000033.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.